Avail Clinical Research Announces Diabetes Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida
Summary
Press Releases Avail Clinical Research Press Release Receive press releases from Avail Clinical Research: By Email RSS Feeds: Avail Clinical Research Announces Diabetes Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida DeLand, FL, February 17, 2010 --( The research studies will enroll those already diagnosed with diabetes, which includes symptoms like excessive thirst and increased urination, fatigue, weight loss, and red, swollen, tender gums.Avail Clinical Research will not take volunteers who: - have any evidence or treatment of malignancy within the previous 5 years, - have a history of alcohol or substance abuse within the previous 5 years, - have used an investigatory drug or participated in an investigatory study within 30 days of the screening, - are pregnant, or -are breast-feeding.“We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from diabetes,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand." Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.The research studies will enroll those already diagnosed with diabetes, which includes symptoms like excessive thirst and increased urination, fatigue, weight loss, and red, swollen, tender gums.Avail Clinical Research will not take volunteers who:- have any evidence or treatment of malignancy within the previous 5 years,- have a history of alcohol or substance abuse within the previous 5 years,- have used an investigatory drug or participated in an investigatory study within 30 days of the screening,- are pregnant, or-are breast-feeding.Avail Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications.